Biel, Thomas G.
Aryal, Baikuntha
Gerber, Michael H.
Trevino, Josè G.
Mizuno, Naoko
Rao, V. Ashutosh
Funding for this research was provided by:
U.S. Department of Health & Human Services | U.S. Food and Drug Administration
Article History
Received: 9 December 2019
Revised: 10 April 2020
Accepted: 14 April 2020
First Online: 15 June 2020
Conflict of interest
: This project was supported in part by an appointment to the Research Participation Program at the Office of Biotechnology Products in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA), administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and FDA. The funding source had no part in the study design, data collection/analysis, decision to publish, or preparation of the manuscript. The authors have no conflicts of interests. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.